Browse > Article
http://dx.doi.org/10.5487/TR.2008.24.3.219

Toxicity Screening of Single Dose of Inorganic and Organic Arsenics on Hematological and Serum Biochemical Parameters in Male Cynomolgus Monkeys  

Kim, Choong-Yong (Korea Institute of Toxicology, KRICT)
Han, Kang-Hyun (Korea Institute of Toxicology, KRICT)
Heo, Jeong-Doo (Korea Institute of Toxicology, KRICT)
Han, Eui-Sik (National Institute of Toxicological Research)
Yum, Young-Na (National Institute of Toxicological Research)
Lee, Jin-Young (National Institute of Toxicological Research)
Park, Kyung-Su (Advanced Analysis Center, Korea Institute of Science and Technology)
Im, Ruth (Dept. Preventive Medicine, College of Medicine, Chung-Ang University)
Choi, Seong-Jin (Dept. Preventive Medicine, College of Medicine, Chung-Ang University)
Park, Jung-Duck (Dept. Preventive Medicine, College of Medicine, Chung-Ang University)
Publication Information
Toxicological Research / v.24, no.3, 2008 , pp. 219-225 More about this Journal
Abstract
A screening study of the acute toxicity of organic arsenics such as arsenobetaine and arsenocholine, a product of arsenic methylation metabolite, and inorganic arsenic was carried out to examine hematological and serum biochemical parameters in cynomolgus monkeys(Macaca fascicularis). We found soft and liquid feces, and vomiting in all treated groups with inorganic and organic arsenics. The monkeys in inorganic arsenic-treated group showed a significant increase in vomiting frequency compared with those in three organic arsenics-treated groups. These results suggest that inorganic arsenic might be more toxic than three other organic arsenics tested. The monkeys in inorganic arsenic-treated group showed a decrease in platelet and an increase in monocyte on day 4 and the monkeys in arsenocholine-treated group showed an increase in reticulocyte percentage on day 8. The monkeys in inorganic-treated group also showed decreases in AST and ALT values and the monkeys in arsenobetaine-treated group showed a decrease in AST value and an increase in T-CHO value. However, these hematological and biochemical changes were within the physiological ranges, showing that the single dose of inorganic and organic arsenics did not affect at least hematological and serum biochemical parameters. The present study of toxicity with single dose of arsenics provides valuable indicators for longer term study of toxicity of repeated doses of arsenics in primates.
Keywords
Cynomolgus monkeys; Organic arsenic; Toxicity screening; Single dose;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim, C.Y., Lee, H.S., Han, S.C., Heo, J.D., Kwon, M.S., Ha, C.S. and Han, S.S. (2005). Hematological and serum biochemical values in cynomolgus monkeys anesthetized with ketamine hydrochloride. J. Med. Primatol., 34, 96-1000   DOI   ScienceOn
2 Li, W., Wanibuchi, H., Salim, E.I., Yamamoto, S., Yoshida, K., Endo, G. and Fukushima, S. (1998). Promotion of NCIBlack- Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. Cancer Lett., 134, 29-36   DOI   ScienceOn
3 Lin, S., Cullen, W.R. and Thomas, D.J. (1999). Methylasenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol., 12, 924-930   DOI   ScienceOn
4 Oya-Ohta, Y., Kaise, T. and Ochi, T. (1996). Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat. Res., 357, 123-129
5 Sakurai, T. (2002). Biological effects of organic arsenic compounds in seafood. Appl. Organomet. Chem., 16, 401-405   DOI   ScienceOn
6 Tam, G.K.H., Charbonneau, S.M., Bryce, F., Pomroy, C. and Sandi, E. (1979). Metabolism of inorganic arsenic ($^{74}As$) in humans following oral ingestion. Toxicol. Appl. Pharmacol., 50, 319-322   DOI   ScienceOn
7 Yamanaka, K., Hasegawa, A., Sawamura, R. and Okada, S. (1989). DNA strand breaks in mammalian tissues induced by methylarsenics. Biol. Trace Elem. Res., 21, 413-417   DOI
8 Vahter, M., Marafante, E. and Dencker, L. (1984). Tissue distribution and retention of $^{74}As$-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol., 13, 259-264   DOI
9 Brown, J.L., Kitchin, K.T. and George, M. (1997). Dimethylarsinic acid treatment alters six different rat biochemical parameters: relevance to arsenic carcinogenesis. Terato- genesis Carcinog. Mutagen, 17, 71-84   DOI   ScienceOn
10 Guha Mazumder, D.N., Haque, R., Ghosh, N., De, B.K., Santra, A., Chakraborty, D. and Amith, A.H. (1998). Arsenin levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int. J. Epidemiol., 27, 871-877   DOI   ScienceOn
11 Charbonneau, S.M., Tam, G.K.H., Bryce, F., Zawidzka, Z. and Sandi, E. (1979). Metabolism of orally administered inorganic arsenic in the dog. Toxicol. Lett., 3,107-113   DOI   ScienceOn
12 Kreppel, H., Bauman, J., Liu, J., McKim, J.M. Jr. and Klaassen, C.D. (1993). Induction of metallothionein by arsenicals in mice. Fundam. Appl. Toxicol., 20, 184-189   DOI   ScienceOn
13 Buchet, J.P., Lauwerys, R. and Roels, H. (1981). Comparison of urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health, 48, 71-79   DOI
14 Rasmussen, R.E. and Menzel, D.B. (1997). Variation in arsenic-induced sister chromatid exchange in human lymphocytes and lymphoblastoid cell lines. Mutat. Res., 386, 299-306   DOI   ScienceOn
15 Moore, M.M., Harrington-Brock, K. and Doerr, C.L. (1997). Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res., 386, 279-290   DOI   ScienceOn
16 Vahter, M., Marafante, E., Lindgren, A. and Dencker, L. (1982). Tissue distribution and subcellular binding of arsenic in marmoset monkeys after injection of $^{74}As$-arsenite. Arch. Toxicol., 51, 65-77   DOI
17 Gad, S.C. and Chengelis, C.P. (1998). Acute toxicology testing (2nd edition), Academic Press, pp. 320-330
18 Hughes, M.F. and Kenyon, E.M. (1998). Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J. Toxicol. Environ. Health, 53, 95-112   DOI   ScienceOn
19 Uede, K. and Furukawa, F. (2003). Clinical and laboratory investigations skin manifestations in acute arsenic poisoning from the Wakayama curry-poinsoning incident. Br. J. Dermatol., 149, 757-762   DOI   ScienceOn
20 Vahter, M. (2000). Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett., 112-113, 209-217   DOI   ScienceOn
21 Vahter, M. (1999). Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog., 82, 69-88
22 Vega, L., Styblo, M., Patterson, R., Cullen, W., Wang, C. and Germolec, D. (2001). Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol., 172, 225-232   DOI   ScienceOn
23 Crecelius, E.A. (1977). Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect., 19,147-150   DOI
24 Styblo, M., Serves, S.V., Cullen, W.R. and Thomas, D.J. (1997). Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol., 10, 27-33   DOI   ScienceOn
25 Vahter, M. (1981). Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ. Res., 25, 286-293   DOI   ScienceOn
26 Bertolero, F., Marafante, E., Edel, R.J., Pietra, R. and Sabbioni, E. (1981). Biotransformation and intracellular binding of arsenic in tissues of rabbit after intraperitioneal administration of $^{74}As$ labeled arsenite. Toxicology, 20, 35-44   DOI   ScienceOn
27 Sakurai, T., Kaise, T. and Matsubara, C. (1998). Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem. Res. Toxicol., 11, 273-283   DOI   ScienceOn
28 Mandal, B.K. and Suzuki, K.T. (2002). Arsenic round the world: a review, Talanta, 58, 201-235   DOI   ScienceOn
29 Vahter, M. (1994). Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem., 8, 175-182   DOI   ScienceOn
30 Wildfang, E., Radabaugh, T.R. and Aposhian, H.V. (2001). Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology, 168, 213-221   DOI   ScienceOn
31 Styblo, M. and Thomas, D.J. (1997). Binding of arsenicals to proteins in an in vitro methylation system. Toxicol. Appl. Pharmacol., 147, 1-8   DOI   ScienceOn